← Back to All Stocks

MET - MetLife, Inc.

Financials

Price History

About

Industry

Insurance - Life

Employees

46,000

Headquarters

United States


Company Overview

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Price

$81.41

52-Week Range

$67 $84

Dividend Yield

2.97%

Dividend Score

A

Dividend

Yield 2.97%
Annual $2.37
Payout 44%
5Y Avg 2.95%

Valuation

P/E (TTM) 15.7
Fwd P/E 7.4
P/B 1.92
PEG 0.41

Profitability

Profit Margin 4.7%
Op Margin 9.9%
ROE 13.0%
ROA 0.4%

Financial Health

Current Ratio 2.09
Quick Ratio 1.75
Debt/Equity 178%

Cash Flow

Free CF $-17.4B
Op CF $15.5B
Total Cash $27.6B

Performance (12M)

Price Change +0.72%
Total Return +3.53%

Analyst Consensus

Buy

16 analysts

Target: $91 $75 - $106
+12.3% implied

Annual Return Breakdown

Dividend Growth

Most Recent Annual Growth

4.36%

3-Year Avg Growth

4.34%

5-Year Avg Growth

4.32%

Annual Dividends

Year-over-Year Growth

Recent Dividend History

Ex-Dividend Date Amount
May 12, 2026 $0.5925
Feb 03, 2026 $0.5680
Nov 04, 2025 $0.5680
Aug 05, 2025 $0.5680
May 06, 2025 $0.5680
Feb 04, 2025 $0.5450
Nov 05, 2024 $0.5450
Aug 06, 2024 $0.5450
May 06, 2024 $0.5450
Feb 05, 2024 $0.5200
Nov 08, 2023 $0.5200
Aug 07, 2023 $0.5200
May 08, 2023 $0.5200
Feb 06, 2023 $0.5000
Nov 07, 2022 $0.5000
Aug 08, 2022 $0.5000
May 09, 2022 $0.5000
Feb 07, 2022 $0.4800
Nov 08, 2021 $0.4800
Aug 09, 2021 $0.4800